register

News & Trends - Pharmaceuticals

Former NSW Premier criticises Covid vaccine mandates in final speech

Health Industry Hub | August 8, 2024 |

Pharma News: Former New South Wales Liberal Premier Dominic Perrottet bid farewell to his 13-year career in parliament with a valedictory speech critiquing Covid-19 vaccine mandates as a “mistake”.

Perrottet, who recently announced his resignation from the seat of Epping to join mining giant BHP in Washington DC, asserted that strict vaccine mandates lacked consideration for personal freedoms despite their intentions.

“If the impact of vaccines on transmission was limited at best, as is mostly now accepted, the law should have left more room and respect for freedom,” he told parliament in his final speech.

“Without dwelling on every decision, I believe it’s important to point out one mistake which was made by governments here and around the world: the strict enforcement of vaccine mandates,” he said.

He acknowledged vaccines’ role in saving lives but emphasised the impact of mandates on individuals’ employment rights, declaring, “But ultimately mandates were wrong. People’s personal choices shouldn’t have cost them their jobs.”

Addressing broader governance issues, Perrottet advocated for fixed, four-year terms for federal governments to prioritise policy reform over perpetual campaigning.

His departure follows a tenure marked by his ascent to NSW’s youngest premier in 2021, succeeding Gladys Berejiklian.

In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

March PBAC agenda unveiled amid tensions over 'unprecedented' volume of submissions

March PBAC agenda unveiled amid tensions over ‘unprecedented’ volume of submissions

Health Industry Hub | November 29, 2024 |

The Department of Health has released the agenda for the March 2025 Pharmaceutical Benefits Advisory Committee (PBAC) meeting, unveiling plans […]

More


News & Trends - MedTech & Diagnostics

Johnson & Johnson MedTech exits DePuy Synthes spine portfolio

J&J MedTech exits DePuy Synthes spine portfolio

Health Industry Hub | November 29, 2024 |

Johnson & Johnson MedTech will officially exit the DePuy Synthes Spine portfolio in Australia tomorrow, November 30, as part of […]

More


News & Trends - Pharmaceuticals

Home-grown hypertension polypill heads for regulatory approval

Home-grown hypertension polypill heads to regulatory approval

Health Industry Hub | November 29, 2024 |

Australian-supported research has revealed remarkable Phase III clinical trial results for an innovative triple drug combination in the treatment of […]

More


News & Trends - Pharmaceuticals

Will Australia become first country to eliminate HIV transmission by 2030?

Will Australia become first country to eliminate HIV transmission by 2030?

Health Industry Hub | November 29, 2024 |

In the lead-up to World AIDS Day on December 1, the Albanese Government has unveiled the 9th National HIV Strategy, […]

More


This content is copyright protected. Please subscribe to gain access.